To summarize, altered anti-OSE IgM and IgG titers are associated with NAFLD and fibrotic NASH, consistent with findings in atherosclerosis (50, 59, 107, 127), suggesting another pathophysiological pathway in common between NAFLD and atherosclerotic CVD. Here, CD40LG is linked to metabolic dysfunction-associated steatohepatitis.